Investors can Contact the law firm free of charge to learn more about recovering their losses
LOS ANGELES, June 24, 2024 (GLOBE NEWSWIRE) — The Portnoy Law Firm advises investors of Altimmune, Inc. (“Altimmune” or the “Company”) (NASDAQ: ALT) that a class action lawsuit has been filed on behalf of investors. Altimmune investors who lost money on their investment are encouraged to contact Lesley Portnoy, Esq.
Investors are encouraged to contact Attorney Lesley F. Portnoy by phone at 310-692-8883 or by email at [email protected] to discuss their legal claims, or click here to join the case at www.portnoylaw.com. The Portnoy Law Firm can provide a free case evaluation and discuss investors’ options for pursuing claims to recover their losses.
The complaint alleges that throughout the Class Period, Defendants failed to disclose to investors that: (1) Altimmune overstated pemvidutide’s potential to differentiate itself from competing GLP-1 agonists based on the drug’s efficacy and tolerability results observed in the MOMENTUM study; (2) accordingly, the results of the MOMENTUM study were less significant to pemvidutide’s clinical, commercial and competitive prospects than Defendants led investors to believe; (3) as a result, Defendants overstated Altimmune’s prospects of finding a strategic partner to develop pemvidutide; and (4) as a result, Defendants’ positive statements about the Company’s business, operations and prospects were materially misleading and/or lacked a reasonable basis at all relevant times.
Please visit our website to review further information and submit your transaction information.
The Portnoy Law Firm represents investors in claims arising from corporate malpractice. The firm’s founding partner has recovered more than $5.5 billion for injured investors. Attorney Advertising. Past results do not guarantee similar results.
Lesley F. Portnoy, Esq.
Admitted to the bar in California and New York
[email protected]
310-692-8883
www.portnoylaw.com
Lawyer advertising
